NatureWise will commercially develop HDAC8 inhibitors patented by City of Hope, collaborators.
City of Hope today announced that it has licensed its HDAC8 inhibitors patent exclusively to NatureWise Biotech & Medicals Corporation, a pharmaceutical company in Taipei, Taiwan.
Read more:
https://www.cityofhope.org/news/city-of-hope-naturewise-announce-license-agreement